Patents by Inventor Yong Hyo Kim

Yong Hyo Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions for inhibiting angiogenesis comprising plant-derived natural compound
    Patent number: 10478440
    Abstract: The present invention provides a pharmaceutical composition for inhibiting angiogenesis containing a plant-derived natural compound which can be effective for preventing or treating disorders or diseases associated with angiogenesis. The compound used as an active ingredient in the pharmaceutical composition of the present invention suppresses VEGF-induced angiogenic responses without cytotoxicity at a low concentration by inhibiting the expression of an anti-angiogenic factor (for example, VEGF), and thus remarkably improves the safety of a drug.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: November 19, 2019
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Ho Jeong Kwon, Yong Hyo Kim
  • PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS COMPRISING PLANT-DERIVED NATURAL COMPOUND
    Publication number: 20170239266
    Abstract: The present invention provides a pharmaceutical composition for inhibiting angiogenesis containing a plant-derived natural compound which can be effective for preventing or treating disorders or diseases associated with angiogenesis. The compound used as an active ingredient in the pharmaceutical composition of the present invention suppresses VEGF-induced angiogenic responses without cytotoxicity at a low concentration by inhibiting the expression of an anti-angiogenic factor (for example, VEGF), and thus remarkably improves the safety of a drug.
    Type: Application
    Filed: May 10, 2017
    Publication date: August 24, 2017
    Inventors: Ho Jeong KWON, Yong Hyo KIM
  • PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS COMPRISING PLANT-DERIVED NATURAL COMPOUND
    Publication number: 20140303148
    Abstract: The present invention provides a pharmaceutical composition for inhibiting angiogenesis containing a plant-derived natural compound which can be effective for preventing or treating disorders or diseases associated with angiogenesis. The compound used as an active ingredient in the pharmaceutical composition of the present invention suppresses VEGF-induced angiogenic responses without cytotoxicity at a low concentration by inhibiting the expression of an anti-angiogenic factor (for example, VEGF), and thus remarkably improves the safety of a drug.
    Type: Application
    Filed: November 28, 2012
    Publication date: October 9, 2014
    Inventors: Ho Jeong Kwon, Yong Hyo Kim